Financhill
Back

ProShares UltraShort Nasdaq Biotech Vs. Gorman-Rupp Industry Stock Comparison

Sell
20

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
17.60
Seasonality Move:
-10.36%
Buy
66

GRC
Gorman-Rupp

Last Price:
32.55
Seasonality Move:
1.42%
Sell
20
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?

  • The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $17.59. The Score for BIS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
66
Gorman-Rupp (GRC) is a Buy

Is Gorman-Rupp a Buy, Sell or Hold?

  • The current Gorman-Rupp [GRC] share price is $32.60. The Score for GRC is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • GRC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BIS Stock Price Chart

What is ProShares UltraShort Nasdaq Biotech's stock price today?

  • The ProShares UltraShort Nasdaq Biotech share price today is $17.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing slight buying pressure.

GRC Stock Price Chart

What is Gorman-Rupp's stock price today?

  • The Gorman-Rupp share price today is $32.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRC is experiencing buying pressure, which is a positive indicator for future bullish movement.

BIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 38.43 Sell
Chaikin Money Flow: 580 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.93 - 20.33) Sell
Bollinger Bands (100): (17.19 - 19.11) Sell

GRC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.94 Sell
Relative Strength Index (14 RSI): 37.3 Sell
Chaikin Money Flow: 54153 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.28 - 35.6) Sell
Bollinger Bands (100): (33.38 - 37.66) Sell

BIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.86 Sell
20-day SMA: 18.77 Sell
50-day SMA: 18.66 Sell
200-day SMA: 20.25 Sell
8-day EMA: 17.84 Sell
20-day EMA: 18.4 Sell
50-day EMA: 18.62 Sell
200-day EMA: 19.59 Sell

GRC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.94 Sell
20-day SMA: 33.37 Sell
50-day SMA: 35.99 Sell
200-day SMA: 33.73 Sell
8-day EMA: 32.86 Sell
20-day EMA: 33.61 Sell
50-day EMA: 34.87 Sell
200-day EMA: 33.59 Sell

ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Gorman-Rupp Earnings Growth & GRC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.08 per share, an increase this year of $0.27 per share, and an increase next year of $0.32 per share.

ProShares UltraShort Nasdaq Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Gorman-Rupp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):